Current Opinion in Oncology

Papers
(The TQCC of Current Opinion in Oncology is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Neoadjuvant immunotherapy in melanoma: pathological response as a surrogate endpoint?64
Is there still a place for lymph node dissection for stage III melanoma since the approval of adjuvant therapy46
Collecting information from all sarcoma reference cancer centres worldwide: achievement and next steps42
Role of PSMA PET/CT in imaging and management of prostate cancer36
The role of signaling lymphocyte activation molecule family receptors in hematologic malignancies31
Treatments and challenges in advanced prostate cancer29
Content features and its implementation in novel app-based psycho-oncological interventions for cancer survivors: a narrative review24
Editorial introductions24
State of the art and upcoming trends in HER2-directed therapies in gastrointestinal malignancies22
Harnessing dendritic cells for innovative therapeutic cancer vaccines21
First and further-line multidisciplinary treatment of retroperitoneal sarcomas21
Progress in diagnosis and treatment of checkpoint inhibitor pneumonitis20
Epigenetic dynamics of aging and cancer development: current concepts from studies mapping aging and cancer epigenomes20
Psycho-oncology interventions focusing on fatigue and sleep disturbances18
Neurorehabilitation in brain tumours: evidences and suggestions for spreading of knowledge and research implementation17
Beyond ‘the good, the bad and the ugly’: let us put rectal cancer patients at the centre of the decision making17
Biomarkers and immunotherapy: where are we?16
Indications and technique of minimally invasive surgery in early-stage cervical cancer15
State-of-the-art and trends in fibroblast growth factor receptor-directed therapies in gastro-intestinal malignancies14
Editorial introductions14
Editorial introductions13
Impact of sentinel node use in lymphedema formation among gynecologic cancer patients13
Safety of assisted reproductive techniques in gynecological cancer patients13
Neoadjuvant and adjuvant approaches in gastroesophageal cancers13
Can we yet use tertiary lymphoid structures as predictive biomarkers for immunotherapy response in melanoma?13
New hopes in relapsed refractory primary central nervous system lymphoma13
WHO 2021 and beyond: new types, molecular markers and tools for brain tumor classification12
Pregnancy-related hormonal changes and thyroid growth: do they have an impact on the higher incidence of differentiated thyroid cancer in women?12
Local treatment in patients with hereditary breast cancer: decision-making process in low-, moderate-, high-penetrance pathogenic germline mutation carriers12
Enhancing proactive life-sustaining treatment preference documentation in advanced cancer care: barriers and recommendations12
How to prevent human papillomavirus-related oropharyngeal cancer?12
Controversies in central nervous system prophylaxis of high-risk diffuse large B-cell lymphoma11
Circulating tumor DNA in breast cancer: a biomarker for patient selection11
Immunomodulation for hepatocellular carcinoma therapy: current challenges11
Liquid biopsy in brain tumors: moving on, slowly11
Melanoma with genetic alterations beyond the BRAF V600 mutation: management and new insights11
A meta-analysis of the efficacy and toxicity of tyrosine kinase inhibitors in treating patients with different types of thyroid cancer: how to choose drugs appropriately?11
State-of-the-art and upcoming trends in RAS-directed therapies in gastrointestinal malignancies11
Editorial introductions10
Recent advances in precision medicine for acute myeloid leukemia10
Interventions aiming to improve advance care planning uptake in oncology: a scoping review of recent randomized controlled trials10
Dyadic psychosocial interventions for patients with cancer and their caregivers: an update10
Editorial: Lung cancer: continuous progress in diagnosis and treatment10
Editorial introductions10
How to become a Multinational Association of Supportive Care in Cancer-designated center of excellence in supportive care in cancer9
Current evidence of integrative oncology modalities for managing adverse effects and survivorship issues among adolescents and young adult (AYA) cancer patients and survivors9
Pathology and new insights in central nervous system lymphomas9
Machine learning applications and challenges in graft-versus-host disease: a scoping review9
Multiple endocrine neoplasia type 2: towards a risk-based approach integrating molecular and biomarker results9
The 5T's of health disparities in multiple myeloma in Latin America9
Desmoid tumors: who, when and how to treat?9
Antibody–drug conjugates in rare genitourinary tumors: review and perspectives9
Lung cancer screening in never smokers9
A new comprehensive and stratified concept for supportive care in cancer patients8
Hybrid magnetic resonance and PET imaging for prostate cancer recurrence8
State of the art and upcoming trends in claudin-directed therapies in gastrointestinal malignancies8
The changing landscape for patients with relapsed/refractory acute myeloid leukaemia8
Targeting the DNA damage response beyond poly(ADP-ribose) polymerase inhibitors: novel agents and rational combinations8
The role of genetic testing in prostate cancer screening, diagnosis, and treatment8
Biochemically recurrent prostate cancer in the era of EMBARK and PSMA PET imaging: everything has changed, except the patients8
Editorial introductions8
The path to personalized treatment in advanced and metastatic biliary tract cancers: a review of new targeted therapies and immunotherapy8
Editorial introductions7
How to support parenting in patients with cancer and co-parents? From research to practice7
Current role and indications of minimally invasive surgery in gynecologic oncology7
Pathologic diagnosis of lung cancer – recent developments7
Editorial introductions7
Advantages of robotic surgery in obese patients with endometrial cancer7
Editorial introductions7
Application of single-port techniques in endometrial cancer7
Mind the target: programmed death ligand 1 in oesophagogastric cancers7
Less is more in endometrial cancer (SLN, conservative treatment, radical hysterectomy, molecular classification)7
Potential application of artificial intelligence in cancer therapy7
Cellular therapies in sarcoma and other solid tumors6
Advances in the pathogenesis of FLT3-mutated acute myeloid leukemia and targeted treatments6
Targeting cancer stem cell pathways for lung cancer therapy6
Immune checkpoint inhibitors in driver mutation-positive nonsmall cell lung cancer6
Editorial introductions6
Controversies on chemotherapy for early HR+/HER2− breast cancer: the role of anthracyclines and dose intensification6
HER2-positive breast cancer: cotargeting to overcome treatment resistance6
How to monitor the side effects of treatments in cancer patients6
Breast surgery after neoadjuvant therapy6
Sarcoma incidence worldwide: regional differences in histology and molecular subtypes6
When do I ask for a DNA methylation array for primary brain tumor diagnosis?6
Immunotherapies in non-metastatic gastrointestinal cancers6
Question prompt lists to improve communication between cancer patients and healthcare professionals6
Treatment of radiation-associated angiosarcoma6
Editorial introductions6
Preclinical glioma models in neuro-oncology: enhancing translational research6
Adjuvant and neoadjuvant approaches in pancreatic cancer6
Deciphering diffuse glioma immune microenvironment as a key to improving immunotherapy results6
Modeling the management of patients with human epidermal growth factor receptor 2-positive breast cancer with liquid biopsy: the future of precision medicine5
Achievements of international rare cancers networks and consortia in the neuro-oncology field5
HIV-related lymphomas5
How to treat localized Hodgkin lymphoma?5
Immunotherapy of sarcomas with modified T cells5
Endoscopic inguinal lymphadenectomy for vulvar cancer, is it feasible?5
Therapeutic cancer vaccination against telomerase: clinical developments in melanoma5
Clinical management of brain tumors in pregnancy5
Precision, personalization, and quality of life for patients with lymphoma5
Current status of phosphoinotiside-3 kinase inhibitors in blood cancers5
Thymic malignancies: role of immunotherapy and novel approaches5
Molecular oncology: what is needed to speed access to innovative therapies in clinical research?5
Are epigenetic-targeting approaches ready for prime time in neuroendocrine neoplasms?5
Polyamine metabolism in prostate cancer5
Surgical treatment for clinical early-stage expansile and infiltrative mucinous ovarian cancer: can staging surgeries safely be omitted?5
Richter transformation: biological insights, diagnostic challenges and emerging therapies5
Neoadjuvant immune checkpoint blockade enhances local and systemic tumor immunity in head and neck cancer5
Selinexor therapy for multiple myeloma and non-Hodgkin lymphomas5
Update on bi-specific monoclonal antibodies for blood cancers5
Preoperative immunotherapy for head and neck cancers: state of art5
0.13788890838623